Dosidal · Switzerland
Cabazitaxel Sandoz, Konzentrat zur Herstellung einer Infusionslösung
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:67542 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 67542 atc: L01CD04 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2021-04-07 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L01CD04 authorisation_number: 67542 form: KOINF holder: Sandoz Pharmaceuticals AG holder_partner_nr: 1006431 it_number: 07.16.1. name: Cabazitaxel Sandoz, Konzentrat zur Herstellung einer Infusionslösung state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53wCM1ZvIZoz_NwOCPnWPT4IdRcOFobWdOmwn1F1Oo5TjFFMr-4rXj4fatUMxGAQrGSslpm5s2R9-8nJbCUGC9cQVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |